SAN FRANCISCO, CA, UNITED STATES, December 2, 2025 – OKAVA Pharmaceuticals is a clinical-stage company developing medicines to enable dogs and cats to live longer,

Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases, metabolic decline and

Study Offers New Hope for Canine Patients Poorly Controlled with Conventional Treatments

Enhanced Board of Directors will play a crucial role in advancing OKAVA’s mission to redefine pet care

Study Published in BMC Veterinary Research Highlights Months-Long Exenatide Drug Delivery Achieved Through OKAVA’s Innovative OKV-119 Drug Delivery System

Study Offers New Hope for Canine Patients Poorly Controlled with Conventional Treatments